Stock Spotlight Archives - Page 146 of 388

MondayDec 13, 2021 12:37 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Developing Safer, More Effective Psilocybin Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced positive results from a preclinical study focusing on CYB003, one of its psilocybin programs. A recent article quotes CEO Doug Drysdale as saying, “Multiple academic studies have shown that psilocybin may have the potential to revolutionize mental health care, but few companies have addressed the well-known limitations and side effects of oral psilocybin… Cybin has always strived to develop safer and more effective therapies for patients, which has guided our multiple psilocybin programs: CYB001, CYB001 and CYB003.” The positive…

MondayDec 13, 2021 12:20 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market

Nemaura Medical (NASDAQ: NMRD) has developed a platform to monitor multiple chemicals in the blood without needles, replacing traditional invasive methods of diagnosis and health care observations. With the global continuous glucose monitoring (“CGM”) devices market expected to reach $19.04 billion in 2028 from $4.11 billion in 2020, according to an analysis by Reports and Data (https://ibn.fm/UBSIU), key companies in the space, including Nemaura Medical, are ideally positioned to benefit from this growth as they work to meet the needs of the industry. CGM devices enable tracking of blood glucose levels around the clock by monitoring the levels via sensors…

MondayDec 13, 2021 12:07 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Increasing Knowledge of Plant-Based Lifestyle, Products, Recipes

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is playing a foremost role in eliminating the barriers of entry to a plant-based lifestyle through education and an ever-expanding marketplace that offers over 5,000 plant-based products. Some of the barriers, identified by a 2021 peer-reviewed journal article, include the perception that plant-based food options have poor taste in addition to the lack of skills to prepare plant-based meals. The study concluded that education on the plant-based diet with the aim of increasing awareness of the benefits and equipping individuals with skills to procure and prepare plant-based meals could increase plant-based…

FridayDec 10, 2021 1:28 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Expanding Market Reach

StraightUp Resources (CSE: ST) (OTCQB: STUPF), at the beginning of the year, broke down its 2021 exploration program into four elements: historical data review, compilation and interpretation; examining historical drill core (“ENDM” core library, Red Lake); geological mapping and sampling; and geophysical surveys. “The objective was to add new 2021 data to enhance interpretations, locate prime locations for drilling holes and conduct soil sampling to inform the company’s investment decisions and guarantee a return on its investment,” reads a recent article. “So far, these efforts have allowed StraightUp to acquire prime properties with tremendous potential to maximize shareholder wealth. It…

FridayDec 10, 2021 12:37 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Positioned Favorably within Rapidly Growing iGaming Industry

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) is positioned to take a significant share of the growing online gambling market by offering a first-rate experience while ensuring total user privacy. Analysts at Research and Markets expect this space to grow at a CAGR of 11.94% between 2021 and 2026, while Grand View Research projects that it will reach $127.3 billion by 2027, with much of that growth coming from the United States and Asia. “PLGNF provides an innovative multitenant gateway that enables online operators to offer users popular games… The company’s proprietary software combines high-definition live streaming dealers with…

ThursdayDec 09, 2021 2:27 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol as Therapeutic Option for Disease Treatment

InMed Pharmaceuticals (NASDAQ: INM) recently released its Q1 2022 financial results along with a business update showing positive momentum across all of its programs. Following the acquisition of BayMedica Inc. in October that created an industry leader in the manufacture and commercialization of rare cannabinoids, management expects to introduce multiple new, rare cannabinoids in the near future, focusing on high demand, attractive margin products. In late September, InMed commenced the 755-201-EB study, its phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders scientifically known as Epidermolysis Bullosa (“EB”). A recent article…

ThursdayDec 09, 2021 1:59 pm

QualityStocksNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) AI Solution Helping Employers Identify Right Talent, Users Identify Personality Traits

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is poised to benefit from the fact that AI technology may just be what companies need to make decisions on hiring the right talent and personality for a job. DIGI’s Projected Personality Interpreter (“PPI”), which was originally conceived and launched by Darwin Ecosystems, a company that was acquired by DigiMax late last year, evaluates a company’s workforce, brand and culture by revealing the personality traits and sentiments buried in human expression. “By leveraging IBM Watson and a customer algorithm that analyzes applicant responses across…

ThursdayDec 09, 2021 12:56 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a…

WednesdayDec 08, 2021 2:46 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Delivering Evidence-Based DTx, Research Centered Around Psychedelics

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently released an operational update regarding the strategic initiatives of its operating segments – MINDCURE Research and MINDCURE Technology. The update detailed the company’s progress and plans for the immediate future. “As a member of the Digital Therapeutics Alliance, MINDCURE delivers digital therapeutics (‘DTx’) that are evidence-based interventions driven by high-quality software to prevent, manage and treat medical disorders,” reads a recent article. A leader in advanced proprietary technology and research centered around psychedelics, MINDCURE is currently advancing multiple programs and products…

Site Search

Company Search

Category: Stock Spotlight